CIK 0001011060 · Non-accelerated filer<br>Smaller reporting company
Nordicus Partners Corp
Sign in to watch- Ticker
- NORD
- Exchange
- Nasdaq
- Industry
- Services-Management Consulting Services
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043186647
- Phone
- 508-523-3141
- Business address
- 280 SOUTH BEVERLY DR., SUITE 505, BEVERLY HILLS, CA, 90212
- Former names
- EKIMAS Corp, AdvanSource Biomaterials Corp, CARDIOTECH INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-19 | GK Partners ApS 10% owner | Sale | −49,165 | $4.00 | $197K | 3,272,933 |
| 2025-02-18 | AC Nordic ApS 10% owner | Purchase | +2,000 | $5.00 | $10K | 3,145,198 |
| 2025-02-18 | AC Nordic ApS 10% owner | Sale | −4,000 | $1.90 | $8K | 3,141,198 |
| 2025-02-18 | AC Nordic ApS 10% owner | Sale | −3,500 | $1.90 | $7K | 3,137,698 |
| 2025-02-13 | GK Partners ApS 10% owner | Conversion | +11,224 | $8.91 | $100K | 3,322,098 |
| 2025-02-03 | GK Partners ApS 10% owner | Purchase | +11,528 | $4.00 | $46K | 3,372,597 |
| 2025-02-03 | GK Partners ApS 10% owner | Sale | −54,223 | $4.00 | $217K | 3,318,374 |
| 2025-02-03 | GK Partners ApS 10% owner | Sale | −7,500 | $3.00 | $23K | 3,310,874 |
| 2025-01-13 | Rouf Henrik Chief Executive Officer | Sale | −3,362 | $4.16 | $14K | 42,640 |
| 2025-01-13 | GK Partners ApS 10% owner | Conversion | +1,504 | $8.97 | $13K | 3,361,069 |
| 2025-01-03 | Rouf Henrik Chief Executive Officer | Sale | −10,000 | $5.00 | $50K | 46,002 |
| 2024-12-19 | GK Partners ApS 10% owner | Conversion | +10,000 | $10.00 | $100K | 3,359,565 |
| 2024-11-15 | Rouf Henrik Chief Executive Officer | Sale | −2,500 | $6.00 | $15K | 56,002 |
| 2024-11-15 | Yankowitz Bennett J. Chief Financial Officer | Grant or award · Stock Option | +125,000 | 125,000 | ||
| 2024-11-15 | Yankowitz Bennett J. Chief Financial Officer | Grant or award · Stock Option | +125,000 | 250,000 | ||
| 2024-11-15 | Rouf Henrik Chief Executive Officer | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2024-11-15 | Rouf Henrik Chief Executive Officer | Grant or award · Stock Option | +250,000 | 500,000 | ||
| 2024-11-12 | ABCHill Holding ApS 5.33% Owner | Other acquisition | +903,829 | 916,329 | ||
| 2024-11-12 | GK Partners ApS 10% owner | Other acquisition | +1,076,412 | 3,349,568 | ||
| 2024-11-12 | Alteral Therapeutics ApS 10% owner | Other acquisition | +4,030,903 | 5,296,131 |
Page 2 of 11 · 215 trades